380 related articles for article (PubMed ID: 15945344)
41. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.
Janelsins MC; Tejani MA; Kamen C; Peoples AR; Mustian KM; Morrow GR
Expert Opin Pharmacother; 2013 Apr; 14(6):757-66. PubMed ID: 23496347
[TBL] [Abstract][Full Text] [Related]
42. Effectively managing chemotherapy-induced nausea and vomiting.
Middleton J; Lennan E
Br J Nurs; 2011 Sep 22-Oct 13; 20(17):S7-8, S10-2, S14-15. PubMed ID: 22067540
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
Schwartzberg LS
Oncology (Williston Park); 2007 Jul; 21(8):946-53; discussion 954, 959, 962 passim. PubMed ID: 17715696
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy-induced nausea and vomiting: state of the art in 2006.
Schwartzberg L
J Support Oncol; 2006 Feb; 4(2 Suppl 1):3-8. PubMed ID: 16499138
[TBL] [Abstract][Full Text] [Related]
45. [Emetogenic potential of antineoplastic agents based on clinical trials in Japan].
Watanabe T; Handa S; Kato Y
Gan To Kagaku Ryoho; 2015 Mar; 42(3):335-41. PubMed ID: 25812503
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy-induced nausea and vomiting.
Bender CM; McDaniel RW; Murphy-Ende K; Pickett M; Rittenberg CN; Rogers MP; Schneider SM; Schwartz RN
Clin J Oncol Nurs; 2002; 6(2):94-102. PubMed ID: 11889684
[TBL] [Abstract][Full Text] [Related]
47. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
Jordan K; Sippel C; Schmoll HJ
Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
[TBL] [Abstract][Full Text] [Related]
48. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
Hsu ES
Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
[TBL] [Abstract][Full Text] [Related]
49. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
[TBL] [Abstract][Full Text] [Related]
50. Update and new trends in antiemetic therapy: the continuing need for novel therapies.
Feyer P; Jordan K
Ann Oncol; 2011 Jan; 22(1):30-38. PubMed ID: 20947707
[TBL] [Abstract][Full Text] [Related]
51. Optimal management of nausea and vomiting in clinical oncology.
Briscoe K
Oncology (Williston Park); 1989 Aug; 3(8 Suppl):11-5. PubMed ID: 2701574
[TBL] [Abstract][Full Text] [Related]
52. CINV: still troubling patients after all these years.
Aapro M
Support Care Cancer; 2018 Mar; 26(Suppl 1):5-9. PubMed ID: 29556808
[TBL] [Abstract][Full Text] [Related]
53. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.
Jordan K; Gralla R; Jahn F; Molassiotis A
Eur J Pharmacol; 2014 Jan; 722():197-202. PubMed ID: 24157984
[TBL] [Abstract][Full Text] [Related]
54. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
Schwartzberg LS
J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
[TBL] [Abstract][Full Text] [Related]
56. Reduction in nausea and vomiting in children undergoing cancer chemotherapy by either appropriate or sham auricular acupuncture points with standard care.
Yeh CH; Chien LC; Chiang YC; Lin SW; Huang CK; Ren D
J Altern Complement Med; 2012 Apr; 18(4):334-40. PubMed ID: 22515794
[TBL] [Abstract][Full Text] [Related]
57. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy.
Tina Shih YC; Xu Y; Elting LS
Cancer; 2007 Aug; 110(3):678-85. PubMed ID: 17567835
[TBL] [Abstract][Full Text] [Related]
58. Safety of clinical practice guideline-recommended antiemetic agents for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric patients: a systematic review and meta-analysis.
Patel P; Paw Cho Sing E; Dupuis LL
Expert Opin Drug Saf; 2019 Feb; 18(2):97-110. PubMed ID: 30640557
[TBL] [Abstract][Full Text] [Related]
59. Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.
Dupuis LL; Boodhan S; Holdsworth M; Robinson PD; Hain R; Portwine C; O'Shaughnessy E; Sung L;
Pediatr Blood Cancer; 2013 Jul; 60(7):1073-82. PubMed ID: 23512831
[TBL] [Abstract][Full Text] [Related]
60. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
